Abstract:Background: Severe asthma is associated with substantial mortality and has unmet therapeutic need. A subset of severe asthma is characterized by neutrophilic airway inflammation. Classically activated (or M1) macrophages which express IL-12 and IL-23 are associated with airway neutrophilia in asthma. Exogenous IL-25 was reported to suppress intestinal inflammation in animal models of inflammatory bowel diseases via suppressing IL-12 and IL-23 production. We hypothesize that IL-25 ameliorates airway neutrophilia via inhibiting macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma. Methods: In a mouse model of neutrophil-dominant allergic airway inflammation, the effect of mouse recombinant IL-25 on airway inflammation were assessed by H&E staining and bronchoalveolar lavage (BAL) cell counting. The percentage of M1 macrophages in lung tissue and BAL cells were analyzed by flow cytometry. Quantitative PCR and immunostaining were performed to measure the expression of Il12, Il23, and inflammatory cytokines. Mechanistic experiments were performed in primary culture of macrophages from mouse lungs. The expression of IL-12, IL-23 and IL-25 in sputum was analyzed in a cohort of severe asthma and subjects with eosinophilic or non-eosinophilic asthma. Results: Intranasal administration of IL-25 markedly decreased the number of neutrophils in BAL cells in a murine model of neutrophil-dominant allergic airway inflammation. Moreover, exogenous IL-25 decreased the number of M1 macrophages, and reduced the expression of IL-12, IL-23 in the lungs of the mouse model. Exogenous IL-25 also inhibited the expression of inflammatory cytokines IL-1β, IFN-γ, TNF-α and IL-17 A. In vitro, IL-25 suppressed IL-12 and IL-23 expression in lipopolysaccharide (LPS)-stimulated primary culture of mouse pulmonary macrophages. Mechanistically, IL-25 inhibited LPS-induced c-Rel translocation to nucleus via STAT3-dependent signaling. In a cohort of severe asthma, IL-25 protein levels in sputum were significantly lower than control subjects. The transcript levels of IL-12 and IL-23 were increased whereas IL-25 transcripts were decreased in sputum cells from subjects with non-eosinophilic asthma compared to eosinophilic asthma. Conclusions: IL-25 expression is downregulated in subjects with severe or non-eosinophilic asthma. Exogenous IL-25 ameliorates airway neutrophilia, at least in part, via inhibiting macrophage M1 polarization and the expression of IL-12 and IL-23.

Research Progresses on the Correlation Between IL-12 Expression Deficiency and Bronchial Asthma

[Determination of Th1/Th2 Cytokines and Chemokines in Patients with Allergic Diseases and Its Significance].

Interleukin-31 Expression and Relation to Disease Severity in Human Asthma.

Role of Th17/IL-17A in Chronic Inflammatory Airway Diseases

Anti-interleukin-5 in the treatment of bronchial asthma

Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Il-12-Dependent Vascular Cell Adhesion Molecule-1 Expression Contributes to Airway Eosinophilic Inflammation in A Mouse Model of Asthma-Like Reaction

The absence of IL-9 reduces allergic airway inflammation by reducing ILC2, Th2 and mast cells in murine model of asthma

Recent Advance in Regulatory T Cells and Bronchial Asthma

Preventative Tracheal Administration of Interleukin-27 Attenuates Allergic Asthma by Improving the Lung Th1 Microenvironment

T-helper cells and their cytokines in pathogenesis and treatment of asthma

Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice.

Exogenous IL-25 ameliorates airway neutrophilia via suppressing macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma

Detection and Significance of Serum Th17 Cell Related Cytokines in Patients with Bronchial Asthma

Innate-like Lymphocytes and Innate Lymphoid Cells in Asthma

Interleukin (IL)‐25: Pleiotropic Roles in Asthma

Expression of interleukin-17~+ regulatory T cells in peripheral blood of allergic asthma and its clinical significance

Peripheral Pathological ILC2: an Inflammatory Indicator for the Assessment of Asthma Control in Clinics

The contributions of allergen to Th1 and Th2 in allergic bronchial asthma

Effect of genetic variation of IL-13 on airway remodeling in bronchial asthma